We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Evolva Concludes Licensing of EV-077 to Serodus

News   Jan 07, 2014

 
Evolva Concludes Licensing of EV-077 to Serodus
 
 
 

RELATED ARTICLES

Antibody Combo Suppressed HIV Levels in Early Trial

News

In an early trial, a combination of two antibodies suppressed blood levels of HIV for months after treatment in some people.

READ MORE

What Pneumococcus Says to Make You Sick

News

This study of "bacterial linguistics," attempts to identify the "words" that bacteria use to communicate.

READ MORE

Lassa Fever Vaccine Shows Promise and Reveals New Test for Immunity

News

A new Lassa fever and rabies vaccine shows lasting immunity and suggests a new way to test for protection.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE